Patent · US Active

DNA-PK inhibitors

US11008305B2 · kind B2 · utility

0Cited by
123References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 13, 2019
Grant dateMay 18, 2021
Priority date
Expiry dateAug 13, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D521/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.